GlassScriptPhysician profile
Daron C Hitt
NPI 1154313047
$1,435.55
in general payments reported to CMS, 2019-2025
14 companies · $60.29 in 2025
The $60.29 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,035 · 2020: $33.51 · 2021: $84.35 · 2023: $46.57 · 2024: $176 · 2025: $60.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $848.89 | 2019-2023 | Tenoglide |
| Smith+Nephew, INC. | $140.99 | 2024 | Ascension, Nugrip Cmc Implant System, Hat-Trick |
| Pylant Medical | $100.73 | 2019-2023 | |
| Exsomed Corporation | $76.76 | 2019 | |
| Zimmer Biomet Holdings, INC. | $60.29 | 2025 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Endo Pharmaceuticals INC. | $36.24 | 2019-2020 | |
| Orthofix Medical, INC. | $34.91 | 2024 | Cervical-Stim, Physio-Stim, Spinal-Stim |
| Carbofix Orthopedics INC | $34.24 | 2021 | |
| Omnilife Science, INC | $26.07 | 2019 | |
| Sonex Health, INC. | $19.44 | 2021 | |
| Organogenesis INC. | $17.16 | 2023 | Puraply |
| Dynasplint Systems INC. | $15.12 | 2020 | |
| Aesculap Implant Systems, LLC | $14.40 | 2019 | |
| Skeletal Dynamics INC | $10.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daron Hitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.